Australia's Leading Ophthalmic Magazine Since 1975

     Free Sign Up     

Australia's Leading Ophthalmic Magazine Since 1975

     Free Sign Up     

Search Results - October 2017

your search of 'October 2017' has 67 results.

sort by  Recent ▼
showing 1 - 12 of 67 results   

Transitions Optical announces Mini Cooper Convertible winner

The winner of the Transitions Optical ‘Win a Mini’ competition has been revealed. Read more »

Government responds to medical complaints inquiry

The Australian Government has responded to a Senate inquiry into the medical complaints process in Australia, supporting five out of the six recommendations. Read more »

Hopes for eye disease treatment for premature babies

The presence of a disease-fighting immune cell in the eye, discovered by Monash University researchers, could lead to new ways of treating eye disorders in premature babies and diabetic adults. Read more »

RANZCO supports new National Rural Health Commissioner

The Australian Medical Association (AMA) has appointed Professor Paul Worley to the newly created position of National Rural Health Commissioner, in an effort to help rectify shortage of regionally based doctors. Read more »

Sunday Somewhere acquired by Mondottica subsidiary

Brando Eyewear, the luxury subsidiary of Mondottica International, has acquired Australian sunglasses brand Sunday Somewhere. Read more »

Surgery could reverse obesity-related eye damage

New research led by the University of Melbourne’s Associate Professor Robyn Tapp has revealed weight-loss surgery could reverse early eye damage caused by obesity. Read more »

Study: Australian optometrists need more technology training

A UNSW study has suggested optometrists need to undergo more training if they are to properly utilise new eye-imaging technology for the treatment of age-related macular degeneration (AMD). Read more »

Possible treatment for incurable form of macular degeneration

There is new hope for people with dry age-related macular degeneration (AMD) following reports that a breakthrough novel drug has been found to reduce the progression of the disease. Read more »

Researchers receive $1.46m in government grants

Ophthalmic researchers have received close to $1.46 million in funding as part of the latest round of National Health and Medical Research Council (NHMRC) grants. Read more »

Australian biotech receives $20 million investment

Australian-Israeli biotech company Azura Ophthalmics has received US$16 million (AU$20.4 million) in Series B funding to develop treatments for Meibomian Gland Dysfunction (MGD), the number one cause of dry eye disease. Read more »

Macular disease research awarded $600,000

Macular Disease Foundation Australia has awarded $600,000 in grants to further support research for the prevention and treatment of age-related macular degeneration (AMD). Read more »


Hot Stories


Subscribe for Insight in your Inbox

Get Insight with the latest in industry news, trends, new products, services and equipment!